The purpose of this study is to evaluate the effects of Succinate Metoprolol(Betaloc ZOK®) (95 - 190 mg) on heart rate in the Stable angina patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
251
treatment with 47.5mg for two weeks, if tolerated and without Systolic blood pressure\<100mmHg and heart rate \<45 bpm according to 12-lead Electrocardiogram at Week 3, the dosage will be titrated to 95mg and last for another 6 weeks
Treatment with 95mg for two weeks, and if tolerated and without bradycardia symptoms presented, Systolic blood pressure\<100mmHg and heart rate \<45 bpm according to 12-lead Electrocardiogram at Week 3,the dosage will be force titrated to 190mg and last for another 6 weeks
Research Site
Beijing, Beijing Municipality, China
Research Site
Guangzhou, Guangdong, China
Research Site
Tangshan, Hebei, China
Research Site
Zhengzhou, Henan, China
The Impact on 24-hr Average Heart Rate Between Two Groups (Betaloc ZOK® 95mg vs. 190mg)
Difference of the 24-hr average heart rate between two groups after 8 weeks treatment.
Time frame: After 8 weeks treatment in the study
The Impact on 24-hr Average Heart Rate From Baseline Within Groups
Difference of the 24-hr average heart rate within groups from baseline after 8 weeks treatment.
Time frame: After 8 weeks treatment in the study
The Different Impact on 24-hr Average Heart Rate Between Two Groups
Difference of the 24-hr average heart rate between two groups after 2 weeks of treatment.
Time frame: After 2 weeks treatment in the study
The Different Impact on 24-hr Average Heart Rate From Baseline Within Groups
Difference of the 24-hr average heart rate within groups from baseline after 2 weeks treatment.
Time frame: After 2 weeks treatment in the study
The Proportion of Patients With Resting Heart Rate Controlled to ≤60bpm Between Groups
Difference in proportions of patients who had resting heart rate controlled to ≤60 bpm after 2 weeks treatment between groups
Time frame: After 2 weeks treatment
The Proportion of Patients With Resting Heart Rate Controlled to ≤60bpm Between Groups
Difference in proportions of patients who had resting heart rate controlled to ≤60 bpm after 8 weeks treatment between groups
Time frame: After 8 weeks treatment
The Difference of Change From Baseline in Total Ischemic Burden Between Groups
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Research Site
Nanjing, Jiangsu, China
Research Site
Jingzhou, Liaoning, China
Research Site
Shenyang, Liaoning, China
Research Site
Shanghai, Shanghai Municipality, China
Research Site
Taiyuan, Shanxi, China
Research Site
Tianjing, China
Difference in change from baseline in TIB between two groups after 2 weeks treatment. Total Ischemic Burden (TIB) was defined as the sum of product of each ischemia episode lasting time and maximal ST elevation: TIB=Σ(STmax×Tisc).
Time frame: After 2 weeks treatment
The Difference of Change From Baseline in Total Ischemic Burden Between Groups
Difference in change from baseline in TIB between two groups after 8 weeks treatment. Total Ischemic Burden (TIB) was defined as the sum of product of each ischemia episode lasting time and maximal ST elevation: TIB=Σ(STmax×Tisc).
Time frame: After 8 weeks treatment
The Difference of Change From Baseline in Angina Frequency Between Groups
Difference in change from baseline of angina pectoris frequency between two groups after 2 weeks treatment.
Time frame: After 2 weeks treatment
The Difference of Change From Baseline in Angina Frequency Between Groups
Difference in change from baseline of angina pectoris frequency between two groups after 8 weeks treatment.
Time frame: After 8 weeks treatment
The Change From Baseline in Total Cholesterol
Difference of change from baseline in TC after 8 weeks treatment between groups.
Time frame: After 8 weeks treatment
The Change From Baseline in Fasting Plasma Glucose
Difference of change from baseline in FPG after 8 weeks treatment between groups.
Time frame: After 8 weeks treatment
The Change From Baseline in Triglycerides
Difference of change from baseline in TG after 8 weeks treatment between groups.
Time frame: After 8 weeks treatment